The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting

Published:2014-06-23 Issue:8 Volume:94 Page:881-892
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Lu Zhi Hong,Kaliberov Sergey,Zhang Jingzhu,Muz Barbara,Azab Abdel K,Sohn Rebecca E,Kaliberova Lyudmila,Du Yingqiu,Curiel David T,Arbeit Jeffrey M

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest201478.pdf

Reference70 articles.

1. Alberti MO, Deshane JS, Chaplin DD et al. A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism. Gene Therapy 2013;20:733–741.

2. Dong Z, Nor JE . Transcriptional targeting of tumor endothelial cells for gene therapy. Adv Drug Deliv Rev 2009;61:542–553.

3. Nicol CG, Denby L, Lopez-Franco O et al. Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature. FEBS Lett 2009;583:2100–2107.

4. Bradshaw AC, Baker AH . Gene therapy for cardiovascular disease: perspectives and potential. Vasc Pharmacol 2013;58:174–181.

5. Muro S, Koval M, Muzykantov V . Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol 2004;2:281–299.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha-1 antitrypsin deficiency: current therapy and emerging targets;Expert Review of Respiratory Medicine;2023-03-04

2. In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector;Biomedicine & Pharmacotherapy;2023-02

3. Nucleic Acid Delivery to the Vascular Endothelium;Molecular Pharmaceutics;2022-10-17

4. A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology;Viruses;2022-09-30

5. Mucopolysaccharidoses type I gene therapy;Journal of Inherited Metabolic Disease;2021-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3